SIBO: Small Intestinal Bacterial Overgrowth

Written by Empire Medical Training Editorial Team

Medically reviewed by Faride Ramos, MD, FAAMFM, ABAARM Double Board-Certified in Internal & Functional Medicine

Updated June 2026 ·11 min read

SIBO — small intestinal bacterial overgrowth — is exactly what its name describes: too many bacteria living in the small intestine, a stretch of gut that is supposed to stay relatively sparse. It is not a fringe concept. As Dr. Faride Ramos teaches in Empire's functional gut health training, SIBO has been studied for decades and is now actively considered in the differential by internal medicine physicians and gastroenterologists alike, precisely because so many patients labeled with "IBS" turn out to have an overgrowth driving their symptoms.

This guide is written for clinicians who want an accurate, practical understanding of SIBO — what it is, what causes it, how it's evaluated, and why it relapses. It is clinical education within the broader field of gut health, not medical advice, and nothing here is a protocol, dose, or substitute for individualized clinical judgment.

What is SIBO?

In a healthy gut, the small intestine is kept relatively clean. The large intestine is where the dense bacterial population lives — trillions of organisms that ferment fiber, produce short-chain fatty acids, and do the heavy lifting of the microbiome. The small intestine, by contrast, is built for digestion and absorption, and it relies on several defenses to stay low in bacteria. SIBO is what happens when those defenses fail and colonic-type bacteria overgrow or migrate upstream into territory where they don't belong.

The consequence is a timing problem. When bacteria sit in the small intestine, they start fermenting carbohydrates before those nutrients are normally digested and absorbed. That premature fermentation produces gas — and it is the gas, not the bacteria themselves, that drives the most recognizable symptoms. Dr. Ramos frames the formal definition around three criteria that must hold together: the location (small intestine, duodenum or jejunum), a bacterial concentration above roughly 10⁵ CFU/mL, and the recognition that this load is significantly higher than what the small bowel normally carries. There is genuine, ongoing debate in the field about the exact threshold, whether specific bacterial species matter more than total count, and whether some symptoms arise simply from colonic bacteria migrating upward regardless of the absolute number — an honest reflection of a diagnosis that medicine is still refining.

Why SIBO happens

SIBO is best understood not as a single disease but as the common endpoint of failed defenses. Several mechanisms normally keep the small intestine relatively sterile, and SIBO tends to appear when one or more of them breaks down. Understanding which one is at fault in a given patient is the whole game, because it is also what determines whether treatment holds.

Impaired motility — the leading driver

The single most important defense is motility. Between meals, the gut runs a housekeeping wave called the migrating motor complex that sweeps residual contents and bacteria downstream toward the colon. When that sweeping is sluggish or absent, bacteria are allowed to linger and accumulate. This is why SIBO clusters with conditions that damage gut motility: diabetic neuropathy and autonomic neuropathy, scleroderma, chronic intestinal pseudo-obstruction, and irritable bowel syndrome itself. A weak migrating motor complex is, in Dr. Ramos's framing, the mechanism that ties most recurrent cases together.

Low stomach acid

Stomach acid is a chemical barrier — it sterilizes much of what we swallow before it ever reaches the small intestine. When acid is insufficient, that barrier fails and harmful microbes are allowed to overgrow downstream. A major modern cause is long-term proton pump inhibitor use, which suppresses acid and can promote SIBO; autoimmune atrophic gastritis and age-related decline in acid production do the same. This is the same low-acid state that also impairs protein breakdown and the absorption of calcium, iron, folate, and B vitamins.

Structural and anatomic causes

Anything that creates a pocket where flow stalls can seed an overgrowth. Dr. Ramos lists anatomic abnormalities such as small-intestinal diverticula, strictures and obstruction, surgical blind loops, an afferent limb after gastrojejunostomy, and enteric fistulas (as in Crohn's disease). Where contents pool, bacteria multiply.

Predisposing conditions

A long list of conditions raises risk by acting through one of the mechanisms above: chronic pancreatitis, liver cirrhosis, celiac disease, hypothyroidism, immunoglobulin deficiencies, and non-alcoholic steatohepatitis. Certain patient profiles are simply more prone — female sex, older age, diarrhea-predominant IBS, and chronic PPI or narcotic use that lowers stomach acid and slows the gut. The throughline is consistent: identify which defense has failed, because that is what you ultimately have to fix.

SIBO symptoms and the IBS overlap

The classic presentation is a patient who says, in Dr. Ramos's words, “I feel bloated every time I eat, regardless of what I eat.” The dominant complaints are bloating, excess gas, and abdominal distension that worsen after meals — the visible, uncomfortable consequence of bacteria fermenting food too early. Alongside that, patients report altered bowel habits: chronic diarrhea, constipation, or a pattern that swings between them, often with crampy abdominal pain that comes and goes.

As the overgrowth interferes with normal absorption, more telling signs can emerge. Dr. Ramos points to nutrient deficiencies such as low B12, and in more advanced cases fat malabsorption producing oily, floating stools (steatorrhea) and even weight loss. These are clues that the overgrowth is doing real metabolic damage, not just causing discomfort.

The diagnostic catch is that these symptoms overlap heavily with irritable bowel syndrome. A meaningful share of patients carrying an IBS label — particularly the diarrhea-predominant type — have an underlying overgrowth driving the picture, which is exactly why SIBO is so easy to miss and why it deserves to be on the differential. For the broader symptom-based condition it mimics, see our guide to IBS.

The types of SIBO: hydrogen vs methane

Not all SIBO behaves the same way, and the difference comes down to which gas the overgrowing organisms produce. This is more than academic — the gas predicts the bowel pattern and shapes how aggressively the condition is treated.

Hydrogen-dominant SIBO is associated with diarrhea. It is generally considered the milder, more straightforward form. Methane-dominant overgrowth — increasingly described as intestinal methanogen overgrowth (IMO) because the methane producers are technically archaea rather than bacteria — is associated with constipation and tends to be more stubborn, warranting a longer and more involved course. When both gases are present, it often signals a recurrent or relapsing case that needs the most extended treatment.

One nuance Dr. Ramos emphasizes: roughly 20 to 30 percent of the population produces methane as a normal byproduct of carbohydrate metabolism, which is part of why testing for both gases — not hydrogen alone — matters for an accurate picture. The specific cutoffs and how to read a gas curve over time are clinical-interpretation skills taught in the course.

How SIBO is diagnosed

There are two fundamental ways to confirm an overgrowth, and they trade off accuracy against practicality. The direct method is to culture a sample aspirated directly from the small intestine — the most definitive evidence of overgrowth, but, as Dr. Ramos notes candidly, “very troublesome for the practitioner and for the patient to take the sample.” Because obtaining a sterile small-bowel aspirate is invasive and difficult, culture is rarely the practical first move.

That is why breath testing has become the standard. The principle is elegant: exhaled hydrogen and methane are produced almost solely by bacterial fermentation of carbohydrates, not by human cells. A patient ingests a test sugar, and the clinician measures how the breath gases rise over the following hours. An early, brisk rise points to fermentation happening too high up — in the small intestine — consistent with overgrowth. Hydrogen and methane are measured together, since methane-dominant cases would be missed on a hydrogen-only test. A systematic review with meta-analysis supports breath testing as the practical, non-invasive standard for diagnosing SIBO.

Conceptually, that is the whole logic; this guide deliberately stops short of the timing thresholds, gas cutoffs, and curve-interpretation rules that decide a positive result. Those interpretive details — and the supporting urine, serum, and imaging studies used to find structural causes — are exactly where clinician training earns its keep, and they are taught in Empire's course.

Treatment: an overview

Treating SIBO follows a logical arc, and functional medicine organizes it within a broader gut-restoration framework — the kind of structured approach detailed in our gut healing protocol overview. The goal is not simply to kill bacteria; it is to clear the overgrowth, support digestion, and remove whatever allowed the overgrowth in the first place.

Reduce the overgrowth. This is the antimicrobial step. Dr. Ramos teaches that it can be approached pharmaceutically — rifaximin is the best-studied agent, sometimes paired with a second drug in methane-dominant cases — or with evidence-supported botanical antimicrobials such as berberine and oregano oil, which she often prefers as a first line when a patient can tolerate them. Notably, the choice and length of treatment scale with the subtype: hydrogen-dominant cases are generally shorter to correct, methane-dominant cases longer, and dual-gas cases longer still.

Address diet. Dietary strategy is a cornerstone, with low-FODMAP and elemental approaches carrying the strongest evidence specifically for SIBO. The principle — reducing the fermentable substrate that feeds the overgrowth — is covered in our gut health diet guide; the structured implementation is taught in the course.

Fix the root cause and restore motility. This is the step that separates a lasting result from a temporary one. If a sluggish migrating motor complex, low stomach acid, or a structural problem allowed the overgrowth, clearing the bacteria without addressing that cause simply resets the clock. Prokinetic support to keep the gut sweeping, restoring adequate stomach acid where appropriate, and rebuilding the barrier and microbiome are all part of the durable plan.

Why SIBO recurs

If there is one idea to carry away from this guide, it is that SIBO is a symptom of an upstream problem, and treating the bacteria without treating that problem is why so many patients relapse. The antimicrobial clears the current overgrowth, but the conditions that produced it — the impaired migrating motor complex, the suppressed stomach acid, the anatomic pocket where contents stall — are all still there, waiting to seed the next one.

This is the through-line of Dr. Ramos's entire approach to the gut: relief of symptoms is not the same as resolution of cause. A patient who keeps relapsing is usually telling you that motility has not been restored, that a PPI is still suppressing acid unnecessarily, that an undiagnosed structural issue persists, or that an adjacent imbalance such as gut dysbiosis is feeding the problem. The durable answer is to identify and treat the root cause — the discipline that turns SIBO from a recurring frustration into a solvable condition.

Provider training in SIBO

SIBO sits at the intersection of conventional GI medicine and functional medicine, and treating it well demands fluency in both. A clinician needs to recognize the migrating-motor-complex mechanism, interpret a hydrogen-and-methane breath test, distinguish hydrogen from methane-dominant overgrowth and tailor the duration accordingly, choose between pharmaceutical and botanical antimicrobials, deploy diet strategically — and, above all, chase the root cause so the condition does not return.

Empire's Functional Gut Health Training, developed and taught by Dr. Faride Ramos, MD, builds exactly this competency. It teaches SIBO not as a memorized checklist but as clinical reasoning — the same reasoning that lets you tell an IBS mimic from a true overgrowth and build a plan that holds.